SenzaGen broadens non-animal offering for medical devices with more tests and tailored consulting services – strengthens market presence and realizes synergies from acquisition
SenzaGen receives SEK 1m follow-on order for GARD®skin Dose-Response from one of the world’s largest cosmetics companies
SenzaGen receives SEK 0.7m order for GARD®skin from one of the world’s largest pharmaceuticals companies
SenzaGen’s 2021 Half-Year Report: Positive ESAC opinion on GARD®skin and expanded range of tests open up new commercial opportunities
